We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Pacific Biomarkers' Dr. Amar A. Sethi Honored by Pharmaceutical Executive Magazine as One of 30 Emerging Pharma Leaders of 2011
News

Pacific Biomarkers' Dr. Amar A. Sethi Honored by Pharmaceutical Executive Magazine as One of 30 Emerging Pharma Leaders of 2011

Pacific Biomarkers' Dr. Amar A. Sethi Honored by Pharmaceutical Executive Magazine as One of 30 Emerging Pharma Leaders of 2011
News

Pacific Biomarkers' Dr. Amar A. Sethi Honored by Pharmaceutical Executive Magazine as One of 30 Emerging Pharma Leaders of 2011

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Pacific Biomarkers' Dr. Amar A. Sethi Honored by Pharmaceutical Executive Magazine as One of 30 Emerging Pharma Leaders of 2011"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Pacific Biomarkers, Inc., has announced that Amar A. Sethi, MD, PhD, the Company's Vice President of Research and Development, has been named one of 30 emerging pharma leaders in the June 2011 issue of Pharmaceutical Executive.

An article titled "Emerging Pharma Leaders 2011: Managing in the Era of Lean" includes profiles of 30 individuals. The profile for Dr. Sethi begins, "An academic background in clinical chemistry combined with a solid understanding of a key therapeutic segment - lipid control medications - set the foundation for Pacific Biomarkers vice president for research and development Dr. Amar Sethi's career as a pathfinder in drug development."

"We are very pleased and proud that Amar has been recognized with this distinguished honor. PBI is extremely fortunate to have a physician-scientist of Dr. Sethi's stature as a valuable member of our team," said Ron Helm, PBI's Chairman and Chief Executive Officer.

Helm continued, "PBI is committed to scientific and commercial excellence as our fundamental mission to develop novel biomarkers, and Dr. Sethi's leadership in spearheading our efforts exemplifies this commitment."

Mr. Helm concluded by saying: "Dr. Sethi's leadership and experience will continue to play a major role in the company's initiatives for the development of custom biomarker services and custom assay development in the rapidly growing clinical biomarker space."

Dr. Sethi, along with the 29 others, will be honored at a dinner in October.

Advertisement